✦ LIBER ✦

Safety, tolerability, and immunogenicity of an inactivated hepatitis A vaccine: effects of single and booster injections, and comparison to administration of immune globulin

✍ Scribed by Daniel Shouval; Yaffa Ashur; Ruth Adler; John A. Lewis; William Miller; Barbara Kuter; Leora Brown; David R. Nalin

Book ID: 118566322
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 465 KB
Volume: 18
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(05)80375-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Single and booster dose responses to an

Single and booster dose responses to an inactivated hepatitis A virus vaccine: comparison with immune serum globulin prophylaxis

✍ D. Shouval; Y. Ashur; R. Adler; J.A. Lewis; M.E. Armstrong; J.P. Davide; B. McGu 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 623 KB

An open study of subcutaneous administra

An open study of subcutaneous administration of inactivated hepatitis A vaccine (VAQTA®) in adults: safety, tolerability, and immunogenicity

✍ Thomas Linglöf; Jan van Hattum; Karen M Kaplan; Jennifer Corrigan; Isabelle Duva 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Safety and immunogenicity of a new formu

Safety and immunogenicity of a new formulation of an inactivated hepatitis A vaccine

✍ Ron Dagan; David Greenberg; Polina Goldenbertg-Gehtman; Emmanuel Vidor; Philippe 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Immunogenicity and safety of a new inact

Immunogenicity and safety of a new inactivated Hepatitis A Vaccine: a clinical trial with comparison of administration route

✍ Alain Fisch; Pascal Cadilhac; Emmanuel Vidor; Thierry Prazuck; Alain Dublanchet; 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 637 KB

Erratum to “An open study of subcutaneou

Erratum to “An open study of subcutaneous administration of inactivated hepatitis A vaccine (VAQTA®) in adults: safety, tolerability, and immunogenicity”: [Vaccine 19 (2001) 3968-3971]

✍ Thomas Linglöf; Jan van Hattum; Karen M Kaplan; Jennifer Corrigan; Isabelle Duva 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 33 KB

Single dose inactivated hepatitis A vacc

Single dose inactivated hepatitis A vaccine: Rationale and clinical assessment of the safety and immunogenicity

✍ Dr. P. van Damme; C. Matheï; S. Thoelen; A. Meheus; A. Safary; F. E. André 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 537 KB

## Abstract In comparison with the classical immunisation schedules (0‐1‐6 or 0‐1‐12 months) for hepatitis A, a 0‐ and 12‐ or a 0‐ and 6‐month schedule would have important advantages by reducing the number of injections and discomfort and increasing scheduling convenience and patient compliance. I